Navigation Links
ABAXIS Realigns North American Medical Sales and Marketing
Date:4/7/2009

elease includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Abaxis claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. Specific forward-looking statements contained in this press release are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the company's ability to recruit and retain sales and marketing personnel, the market acceptance of the Company's products and the continuing development of its products, risks associated with manufacturing and distributing its products on a commercial scale, risks associated with entering the human diagnostic market on a larger scale, general market conditions, competition and other risks detailed from time to time in Abaxis' periodic reports filed with the United States Securities and Exchange Commission. Forward-looking statements speak only as of the date the statement was made. Abaxis does not undertake and specifically disclaims any obligation to update any forward-looking statements.

    Contact:   Clint Severson             Lytham Partners, LLC
               Chief Executive Officer    Joe Dorame, Robert Blum and Joe Diaz
               Abaxis, Inc.               602-889-9700
               510-675-6500


'/>"/>
SOURCE Abaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Abaxis, Inc. to Attend Lazard Capital Markets Medical Technologies Conference
2. Abaxis, Inc. to Present at Sidoti & Companys Thirteenth Annual New York Emerging Growth Institutional Investor Forum
3. Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009
4. ABAXIS Announces Launch of Two New Products at the NAVC
5. ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd.
6. Abaxis, Inc. to Present at Sidoti & Companys Sixth Annual Palm Beach Emerging Growth Institutional Investor Forum
7. Abaxis, Inc. to Present at Needham & Companys Eleventh Annual Growth Stock Conference
8. Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status
9. Abaxis, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
10. Abaxis to Report Second Quarter Fiscal 2009 Financial Results Monday, October 27, 2008
11. Abaxis, Inc. to Present at CL Kings Sixth Annual Best Ideas Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... 17 Reportlinker.com announces that a ... its catalogue: ,, http://www.reportlinker.com/p0169956/Top-Ten-Worlds-Leading-Animal-Health-Companies.html ... the animal health industry executives with strategically ... to the development and implementation of effective ... objectives include: ,, To establish ...
(Date:12/17/2009)... following feature is by Devon Herrick, PhD, Senior Fellow ... People often assume they have little control over how ... sickness cannot be scheduled, doctors prescribe treatments and employers ... Americans. However, there are many overlooked ways to trim ... need. ,, Cut your prescription costs: ...
(Date:12/17/2009)... -- The National Council on Disability (NCD) ... Marriott Houston, 5150 Westheimer, Houston, TX, beginning at 8:30 ... 11:00 a.m. on Thursday, January 21, 2010. This meeting ... it is vital to hear from communities around the ... people with disabilities. This meeting will provide another opportunity ...
(Date:12/17/2009)... Maureen Neitz, the husband-and-wife team whose pioneering research may ... vision disorders, as the inaugural recipients of the Jay ... is funded by a $1 million endowment established this ... ,75 and Susan K. Feigenbaum ,74, his wife. The ... , The Neitzes, both of whom are faculty members ...
(Date:12/17/2009)... lung infections , , THURSDAY, Dec. 17 (HealthDay News) -- ... swine flu virus, and researchers say they,ve found a ... severity of the illness appears to be a molecule ... fight off germs and disease. Researchers who analyzed levels ... hospitals last summer found the highest levels in the ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4Health News:Six Ways to Slash Your Health Costs 2Health News:Six Ways to Slash Your Health Costs 3Health News:Six Ways to Slash Your Health Costs 4Health News:National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities 2Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2
... by the Pharmaceutical Research and Manufacturers of America (PhRMA) ... two of the three leading causes of death of ... are currently in clinical trials or under review by ... disease and stroke are still leading causes of death ...
... announces the launch of Global Health TV, a new ... and civil society on the major health issues faced ... is a collaborative project between HBL Media, a London-based ... Health TV website, http: www.globalhealthtv.com, will bring viewers three ...
... With the advent of a possible new blockbuster drug ... alcohol, and drug addictions, global sales of smoking cessation ... revenues of little over $1.1 billion in 2005 to ... Cessation and Addiction Treatments: A World Market Analysis, a ...
... inventor of Pulse CO-Oximetry and Read-Through Motion and Low ... presented at the Pediatric Academic Societies' (PAS) ... that switching to Masimo SET pulse oximetry technology can ... infants developing retinopathy of prematurity (ROP) by 40%.(1) One ...
... risk factors beyond those expected from weight loss in ... due to the drug itself, reports an article in ... ,Advertisements for rimonabant (sold under the ... 50% of the effects on cardiometabolic risk factors ...
... Medarex, Inc. today announced a collaborative research agreement ... Chemical Holdings Corporation . The two companies expect ... against a Mitsubishi target for the potential treatment ... Medarex's UltiMAb Human Antibody Development System(R) to generate ...
Other Medicine News:Health News:More Than 270 Medicines in Testing for Heart Disease and Stroke 2Health News:Masimo SET Pulse Oximetry Technology Significantly Reduce the Risk of ROP 2Health News:Masimo SET Pulse Oximetry Technology Significantly Reduce the Risk of ROP 3Health News:Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned 2
(Date:12/16/2009)... Accuray Incorporated (Nasdaq: ARAY ), a ... that its president and chief executive officer, Euan S. ... Annual J.P. Morgan Healthcare Conference in San Francisco on ... ET. ,, A live webcast of each presentation ... of the Company,s Web site at http://www.accuray.com . ...
(Date:12/16/2009)... A new application developed by American Imaging Management® ... pharmaceuticals has increased health plan staff productivity and ... ,, AIM, a leading diagnostic imaging benefit management ... over 35 million consumers and an operating subsidiary ... adapted the successful clinical and technology platform used ...
(Date:12/16/2009)... REYKJAVIK, Iceland, December 16 Scientists at,deCODE ... journal Nature the,discovery of a version of a ... genome (SNP) with a major impact on susceptibility ... T2D variant is not only large, but unusual:,if ... variant increases risk of,T2D by more than 30% ...
Breaking Medicine Technology:Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4GARP makes the difference 8832 1GARP makes the difference 8832 2Duke Harvard researchers to monitor bonobo reintroduction 8829 1Duke Harvard researchers to monitor bonobo reintroduction 8829 2Scientific evidence of health problems from past contamination of drinking water at Camp Lejeune is limited and unlikely to be resolved with further s 8826 1Scientific evidence of health problems from past contamination of drinking water at Camp Lejeune is limited and unlikely to be resolved with further s 8826 2Scientific evidence of health problems from past contamination of drinking water at Camp Lejeune is limited and unlikely to be resolved with further s 8826 3Scientific evidence of health problems from past contamination of drinking water at Camp Lejeune is limited and unlikely to be resolved with further s 8826 4
... NEW YORK, April 14 The Michael J. Fox,Foundation ... clinical trial,to investigate the potential of inosine -- a ... body -- to slow or stop the progression of,Parkinson,s ... Foundation,s LEAPS (Linked Efforts,to Accelerate Parkinson,s Solutions) 2007 initiative. ...
... Researchers at,the Barbara Ann Karmanos Cancer Institute ... to cancer patients. Today, at the American,Association ... researchers,Vitaly Balan, Ph.D., Pratima Nangia-Makker, Ph.D., and ... rs4644 Foretells Human Breast,Cancer Risk Associated with ...
Other Medicine Technology:Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine 2Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine 3Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women 2Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: